See more : Mannai Corporation Q.P.S.C. (MCCS.QA) Income Statement Analysis – Financial Results
Complete financial analysis of Envoy Medical, Inc. (COCH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Envoy Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Finanza.tech S.p.A. (FTC.MI) Income Statement Analysis – Financial Results
- Racing Force S.P.A. (RFG.MI) Income Statement Analysis – Financial Results
- Jadestone Energy plc (JSE.L) Income Statement Analysis – Financial Results
- Thanasiri Group Public Company Limited (THANA.BK) Income Statement Analysis – Financial Results
- Sino Horizon Holdings Limited (2923.TW) Income Statement Analysis – Financial Results
Envoy Medical, Inc. (COCH)
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 316.00K | 237.00K | 310.00K | 0.00 |
| Cost of Revenue | 789.00K | 957.00K | 769.00K | 0.00 |
| Gross Profit | -473.00K | -720.00K | -459.00K | 0.00 |
| Gross Profit Ratio | -149.68% | -303.80% | -148.06% | 0.00% |
| Research & Development | 8.96M | 4.52M | 3.94M | 0.00 |
| General & Administrative | 7.28M | 3.47M | 2.47M | 0.00 |
| Selling & Marketing | 1.67M | 885.00K | 0.00 | 0.00 |
| SG&A | 8.94M | 3.47M | 2.47M | 701.00 |
| Other Expenses | 0.00 | -7.22M | -1.80M | 0.00 |
| Operating Expenses | 17.90M | 7.99M | 6.41M | 701.00 |
| Cost & Expenses | 18.69M | 8.94M | 7.18M | 701.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 133.00K | 75.00K | 71.00K | 206.30K |
| EBITDA | -18.24M | -8.63M | -6.80M | -700.00 |
| EBITDA Ratio | -5,771.52% | -3,641.77% | -2,193.55% | 0.00% |
| Operating Income | -18.37M | -8.71M | -6.87M | -700.00 |
| Operating Income Ratio | -5,813.61% | -3,673.42% | -2,216.45% | 0.00% |
| Total Other Income/Expenses | -11.54M | -7.22M | -1.80M | -1.00 |
| Income Before Tax | -29.91M | -15.92M | -8.68M | -701.00 |
| Income Before Tax Ratio | -9,464.56% | -6,718.57% | -2,798.39% | 0.00% |
| Income Tax Expense | 0.00 | -153.49K | -165.56K | -206.30K |
| Net Income | -29.91M | -15.92M | -8.68M | -701.00 |
| Net Income Ratio | -9,464.56% | -6,718.57% | -2,798.39% | 0.00% |
| EPS | -2.38 | -1.57 | -0.85 | 0.00 |
| EPS Diluted | -2.38 | -1.57 | -0.85 | 0.00 |
| Weighted Avg Shares Out | 12.55M | 10.15M | 10.15M | 60.38M |
| Weighted Avg Shares Out (Dil) | 12.55M | 10.15M | 10.15M | 60.38M |
MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger (NASDAQ: COCH)
WASHINGTON , Jan. 22, 2024 /PRNewswire/ -- MCRA, LLC, a leading medical device and biologics focused clinical research organization (CRO) and advisory firm integrating seven core services [U.S. and International Regulatory Affairs, Clinical Trial Operations, Reimbursement and Market Access, Healthcare Compliance, Cybersecurity,...
Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems
Expanding Innovation Portfolio to Support Delivering Hearing to Patients in Innovative Ways WHITE BEAR LAKE, Minnesota, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems,...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Envoy Medical, Inc.- COCH
NEW YORK , Jan. 14, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Envoy Medical, Inc. ("Envoy" or the "Company") (NASDAQ: COCH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Envoy Medical, Inc.- COCH
NEW YORK, Jan. 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Envoy Medical, Inc. ("Envoy" or the "Company") (NASDAQ: COCH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
COCH LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH
NEW YORK , Dec. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may...
ENVOY ALERT: Bragar Eagel & Squire, P.C. is Investigating Envoy Medical, Inc. on Behalf of Envoy Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Envoy Medical, Inc. (“Envoy” or the “Company”) (NASDAQ: COCH) on behalf of Envoy stockholders. Our investigation concerns whether Envoy has...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business...
Envoy Medical to Host Fireside Chat Event December 7
Analyst Hosted Event to Feature Comprehensive Discussion of Envoy Medical's Products, Interviews with Two Study Investigators and Key Opinion Leaders in Cochlear Implants
Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update
Interim Findings from Early Feasibility Trial Provide Important Learnings and Feedback Ahead of Pivotal Clinical Trial Planned for 2024
Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems
Newly Published Patent Contemplates an Evolving Product Portfolio to Serve the Under-Penetrated Hearing Implant Market WHITE BEAR LAKE, Minnesota, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully...
Source: https://incomestatements.info
Category: Stock Reports